Cargando…
Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number
BACKGROUND: The selection criteria for Barcelona Clinic Liver Cancer (BCLC) intermediate-stage hepatocellular carcinoma (HCC) patients who would truly benefit from liver resection (LR) remain undefined. AIM: To identify BCLC-B HCC patients more suitable for LR. METHODS: We included patients undergoi...
Autores principales: | Hu, Xin-Sheng, Yang, Hui-Yuan, Leng, Chao, Zhang, Zhi-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730440/ https://www.ncbi.nlm.nih.gov/pubmed/36504552 http://dx.doi.org/10.3748/wjg.v28.i44.6271 |
Ejemplares similares
-
Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020) -
Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
por: Zhang, Wei, et al.
Publicado: (2017) -
Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2022) -
Clinical stages of recurrent hepatocellular carcinoma: A retrospective cohort study
por: Yao, Si-Yang, et al.
Publicado: (2021) -
Learning curves of robot-assisted pedicle screw fixations based on the cumulative sum test
por: Yu, Jie, et al.
Publicado: (2021)